Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT07113834
Eligibility Criteria:
Inclusion Criteria:
* Egyptian nationality.
Age: ≥ 18 years.
Confirmed diagnosis of Ankylosing Spondylitis (AS) according to the Modified New York Criteria, including:
Clinical symptoms (e.g., chronic inflammatory back pain, reduced lumbar motion, reduced chest expansion)
Radiographic evidence of sacroiliitis.
Confirmed diagnosis of Acute Anterior Uveitis (AAU) based on:
Ophthalmologic examination (e.g., slit-lamp biomicroscopy)
Ancillary testing (e.g., Optical Coherence Tomography \[OCT\] and/or Fluorescein Angiography \[FA\]).
Presentation to the Spine Clinic of Benha University - Faculty of Medicine between September 2023 and August 2024 with ophthalmic complaints, subsequently referred to the Ophthalmology Clinic.
Complete medical and ophthalmologic records available.
Received treatment for both AS and AAU.
At least one follow-up visit after initiation of treatment.
Exclusion Criteria:
* Non-Egyptian patients.
History of other systemic autoimmune or immunological diseases (e.g., sarcoidosis, Behçet's disease, systemic lupus erythematosus).
Uveitis due to non-autoimmune secondary causes (e.g., infectious uveitis, trauma-related uveitis).
History of ocular surgery prior to the episode of AAU
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07113834
Study Brief:
Protocol Section:
NCT07113834